Enjoy complimentary customisation on priority with our Enterprise License!
The APAC acute myeloid leukemia (AML) treatment market size is forecast to increase by USD 305.8 million at a CAGR of 13.9% between 2023 and 2028. The market is witnessing significant growth due to the high incidence of this cancer type worldwide. According to the American Cancer Society, AML accounts for approximately one-third of all leukemia diagnoses. A key trend in the market is the adoption of Chimeric Antigen Receptor T-cell (CAR-T) therapy for AML treatment. This innovative approach, which involves engineering a patient's own T-cells to target and destroy cancer cells, has shown promising results in clinical trials. However, challenges remain, particularly in developing nations, where the lack of adequate healthcare infrastructure hampers the widespread adoption of advanced treatment modalities. Despite these challenges, the market is expected to grow steadily due to the increasing demand for effective AML treatments and ongoing research and development efforts.
_Treatment_Market_in_APAC_size_abstract_2024_v1.jpg_v4.1.20.webp)
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
